Medtronic earnings rise, sales edge higher amid pressure from currency rates --Company highlights signs of stability in key markets, despite...
NATICK, Mass., Jan. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial...
NATICK, Mass., Dec. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the pricing of a public offering of $2...
Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets...
House lawmakers will propose a $20 billion fee on medical device makers--chopping in half a $40 billion fee approved earlier this month by the...
Boston Scientific Corp. (BSX) swung to a third-quarter gain following a charge-laden period last year, but sales grew less than Wall Street...
Boston Scientific Corp. (BSX) swung to a third-quarter profit as the company recorded a small revenue increase and much smaller unusual charges...
(Updates stock price, adds analyst reaction beginning in 2nd paragraph.) By Peter Loftus Of DOW JONES NEWSWIRES Johnson & Johnson (JNJ) eked...
(Adds details and background throughout, comments from J&J CFO beginning in seventh paragraph.) By Peter Loftus Of DOW JONES NEWSWIRES Johnson...
(Adds detail, background.) By Peter Loftus DOW JONES NEWSWIRES Johnson & Johnson (JNJ) eked out a 1.1% increase in third-quarter profit...
Johnson & Johnson (JNJ) eked out a 1.1% increase in third-quarter profit despite generic competition for several former big sellers pushing...
(Adds details from analyst survey) By Jon Kamp Of DOW JONES NEWSWIRES Heart-device maker St. Jude Medical Inc. (STJ) issued soft preliminary...
(Updates throughout with comments from Medtronic, analysts.) By Jon Kamp Of DOW JONES NEWSWIRES Heart-device maker St. Jude Medical Inc. (STJ...
(Updates to add details on results, share price impact for St. Jude and competitors) By Jon Kamp Of DOW JONES NEWSWIRES Heart-device maker St...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads